Trishula Therapeutics

1 follower


Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.

Industries

Employees

1-10

Links


Org chart

Anil Singhal
President & CEO
Collapse
Alan Luk
VP, CMC
Anh Tran
Head of Clinical Operations
Siddhartha Mitra
Chief Medical Officer

Board & advisors